Publications by authors named "Christina Koop"

Claim this Profile
M
Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories.
Clarissa Gerhauser, Francesco Favero, Thomas Risch, Ronald Simon, Lars Feuerbach, Christina Koop

Cancer Cell· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome.
Katharina Grupp, Bianca Hofmann, Asad Kutup, Kai Bachmann, Dean Bogoevski, Christina Koop

BMC Cancer· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer.
Waldemar Wilczak, Corinna Wittmer, Till Clauditz, Sarah Minner, Stefan Steurer, Christina Koop

Eur Urol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.
Stefan Steurer, Sebastian Dwertmann Rico, Ronald Simon, Sarah Minner, Maria Christina Tsourlakis, Christina Koop

BJU Int· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort.
Tamara L Lotan, Asmus Heumann, Sebastian Dwertmann Rico, Jessica Hicks, Kristen Lecksell, Christina Koop

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
βIII-tubulin overexpression is linked to aggressive tumor features and genetic instability in urinary bladder cancer.
Andrea Hinsch, Aref Chaker, Christian Burdelski, Christina Koop, Maria Christina Tsourlakis

Hum Pathol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer.
Martina Kluth, Ramin Ahrary, Claudia Hube-Magg, Malik Ahmed, Heinke Volta, Christina Koop

Oncotarget· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer.
Patrick Lebok, Magdalena Roming, Martina Kluth, Christina Koop, Cansu Özden

Oncotarget· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p16 upregulation is linked to poor prognosis in ERG negative prostate cancer.
Christoph Burdelski, Tatsiana Dieckmann, Asmus Heumann, Claudia Hube-Magg, Martina Kluth, Christina Koop

Tumour Biol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer.
Maximilian Lennartz, Sarah Minner, Sophie Brasch, Hilko Wittmann, Leonard Paterna, Christina Koop

Clin Cancer Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer.
Nathaniel Melling, Levon Harutyunyan, Claudia Hube-Magg, Martina Kluth, Ronald Simon, Christina Koop

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers.
Christoph Burdelski, Erzen Bujupi, Maria Christina Tsourlakis, Claudia Hube-Magg, Martina Kluth, Christina Koop

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers.
Christoph Burdelski, Sandra Kleinhans, Martina Kluth, Claudia Hube-Magg, Sarah Minner, Christina Koop

Int J Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diverse expression patterns of the EMT suppressor grainyhead-like 2 (GRHL2) in normal and tumour tissues.
Sabine Riethdorf, Sabrina Frey, Sonja Santjer, Malgorzata Stoupiec, Benjamin Otto, Christina Koop

Int J Cancer· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence.
Alexandra Pust, Dominik Kylies, Claudia Hube-Magg, Martina Kluth, Sarah Minner, Christina Koop

Hum Pathol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer.
Nathaniel Melling, Berivan Taskin, Claudia Hube-Magg, Martina Kluth, Sarah Minner, Christina Koop

Prostate· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters.
Nathaniel Melling, Erik Thomsen, Maria Christina Tsourlakis, Martina Kluth, Claudia Hube-Magg, Christina Koop

Carcinogenesis· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of Tumor Heterogeneity in Colorectal Cancers Using Heterogeneity Tissue Microarrays.
Phillip R Stahl, Jessica Schnellert, Christina Koop, Ronald Simon, Andreas Marx

Pathol Oncol Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion.
Katharina Grupp, Laura Roettger, Martina Kluth, Claudia Hube-Magg, Ronald Simon, Christina Koop

Oncol Rep· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer.
Martina Kluth, Ramin Ahrary, Claudia Hube-Magg, Malik Ahmed, Heinke Volta, Christina Koop

Oncotarget· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer.
Christoph Burdelski, Viktor Reiswich, Claudia Hube-Magg, Martina Kluth, Sarah Minner, Christina Koop

Clin Cancer Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion.
Christoph Burdelski, Devi Menan, Maria Christina Tsourlakis, Martina Kluth, Claudia Hube-Magg, Christina Koop

BMC Cancer· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDAC1 overexpression independently predicts biochemical recurrence and is associated with rapid tumor cell proliferation and genomic instability in prostate cancer.
Christoph Burdelski, Oliver M Ruge, Nathaniel Melling, Christina Koop, Ronald Simon

Exp Mol Pathol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy.
Cristina Villares Zabalza, Meike Adam, Christoph Burdelski, Waldemar Wilczak, Corina Wittmer, Christina Koop

Oncotarget· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy.
Maria Christina Tsourlakis, Puya Khosrawi, Philipp Weigand, Martina Kluth, Claudia Hube-Magg, Christina Koop

Int J Mol Sci· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis